Insider: ROBINS CHAD M CEO and Chairman - Adaptive Biotechnologies Corp
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 2,959,249 | 0 | 2,959,249 |
| Value | $38,559,014.47 | $0.00 | $38,559,014.47 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/06/2025 | DDS | 102,218 | Direct | COM | $7.64 | $780,945.52 | 2,959,249 |
| 03/05/2025 | DDS | 81,206 | Direct | COM | $6.98 | $566,817.88 | 2,850,495 |
| 03/05/2025 | DDS | 36,145 | Direct | COM | $6.99 | $252,653.55 | 2,814,350 |
| 02/20/2025 | DDS | 99,107 | Direct | COM | $8.44 | $836,463.08 | 2,576,701 |
| 02/19/2025 | DDS | 186,080 | Direct | COM | $8.46 | $1,574,236.80 | 2,576,701 |
| 02/18/2025 | DDS | 211,160 | Direct | COM | $8.50 | $1,794,860.00 | 2,576,701 |
| 02/14/2025 | DDS | 158,921 | Direct | COM | $8.46 | $1,344,471.66 | 2,576,701 |
| 02/13/2025 | DDS | 100,287 | Direct | COM | $8.44 | $846,422.28 | 2,576,701 |
| 03/05/2024 | DDS | 42,794 | Direct | COM | $3.43 | $146,783.42 | 2,576,701 |
| 03/05/2024 | DDS | 5,879 | Direct | COM | $3.44 | $20,223.76 | 2,619,495 |
| 03/09/2022 | DDS | 14,815 | Direct | COM | $12.46 | $184,594.90 | 1,916,154 |
| 03/08/2022 | DDS | 14,815 | Direct | COM | $11.38 | $168,594.70 | 1,916,154 |
| 03/07/2022 | DDS | 500 | Direct | COM | $12.22 | $6,110.00 | 1,930,469 |
| 03/07/2022 | DDS | 14,315 | Direct | COM | $11.53 | $165,051.95 | 1,916,154 |
| 03/07/2022 | DDS | 4,424 | Direct | COM | $12.01 | $53,132.24 | 1,916,154 |
| 09/10/2021 | DDS | 4,902 | Direct | COM | $38.37 | $188,089.74 | 1,673,559 |
| 09/10/2021 | DDS | 98 | Direct | COM | $39.09 | $3,830.82 | 1,673,461 |
| 09/09/2021 | DDS | 24,753 | Direct | COM | $38.42 | $951,010.26 | 1,678,461 |
| 09/08/2021 | DDS | 11,742 | Direct | COM | $38.34 | $450,188.28 | 1,705,218 |
| 09/08/2021 | DDS | 2,004 | Direct | COM | $39.11 | $78,376.44 | 1,703,214 |
| 07/12/2021 | DDS | 1,501 | Direct | COM | $38.24 | $57,398.24 | 1,716,960 |
| 06/17/2021 | DDS | 4,255 | Direct | COM | $39.76 | $169,178.80 | 1,718,461 |
| 06/17/2021 | DDS | 1,000 | Direct | COM | $38.55 | $38,550.00 | 1,722,716 |
| 06/16/2021 | DDS | 4,745 | Direct | COM | $38.13 | $180,926.85 | 1,723,716 |
| 06/15/2021 | DDS | 19,100 | Direct | COM | $38.22 | $730,002.00 | 1,729,361 |
| 1 2 3 4 5 6 Next Last You are at page 1 of 6 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research